Beijing Succeeder Technology Inc (688338) - Total Liabilities

Latest as of March 2026: CN¥69.11 Million CNY ≈ $10.11 Million USD

Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has total liabilities worth CN¥69.11 Million CNY (≈ $10.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Beijing Succeeder Technology Inc equity growth rate to track the company's year-over-year net asset growth rate.

Beijing Succeeder Technology Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Beijing Succeeder Technology Inc's total liabilities have evolved over time, based on quarterly financial data. See 688338 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Beijing Succeeder Technology Inc Competitors by Total Liabilities

The table below lists competitors of Beijing Succeeder Technology Inc ranked by their total liabilities.

Company Country Total Liabilities
Guizhou Transp Planning
SHG:603458
China CN¥2.70 Billion
Jilin Jinguan Electric Co Ltd Class A
SHE:300510
China CN¥881.84 Million
Colony Bankcorp Inc.
NYSE:CBAN
USA $3.34 Billion
Dynasty Ceramic Public Company Limited
BK:DCC
Thailand ฿3.39 Billion
Angel Oak Financial Strategies Income Term Trust
NYSE:FINS
USA $127.39 Million
Shenzhen Genvict Technologies Co Ltd
SHE:002869
China CN¥421.92 Million
Duratec Ltd
AU:DUR
Australia AU$158.85 Million
North American Construction Group Ltd
TO:NOA
Canada CA$1.36 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Beijing Succeeder Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Beijing Succeeder Technology Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 20.80 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Succeeder Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Succeeder Technology Inc (2016–2025)

The table below shows the annual total liabilities of Beijing Succeeder Technology Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥75.86 Million
≈ $11.10 Million
-25.96%
2024-12-31 CN¥102.46 Million
≈ $14.99 Million
-3.35%
2023-12-31 CN¥106.01 Million
≈ $15.51 Million
-1.34%
2022-12-31 CN¥107.44 Million
≈ $15.72 Million
+70.87%
2021-12-31 CN¥62.88 Million
≈ $9.20 Million
+38.77%
2020-12-31 CN¥45.31 Million
≈ $6.63 Million
-12.86%
2019-12-31 CN¥52.00 Million
≈ $7.61 Million
+9.97%
2018-12-31 CN¥47.28 Million
≈ $6.92 Million
+9.91%
2017-12-31 CN¥43.02 Million
≈ $6.29 Million
-15.43%
2016-12-31 CN¥50.87 Million
≈ $7.44 Million
--

About Beijing Succeeder Technology Inc

SHG:688338 China Medical Devices
Market Cap
$418.59 Million
CN¥2.86 Billion CNY
Market Cap Rank
#13163 Global
#3887 in China
Share Price
CN¥26.95
Change (1 day)
+0.56%
52-Week Range
CN¥23.93 - CN¥35.81
All Time High
CN¥126.75
About

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more